New Guidance on the OIG’s Ability to Exclude Owners, Officers and Managing Employees; Related FDA Statements on Pharmaceutical Executives


On October 20, 2010, the Office of Inspector General (OIG) of the Department of Health and Human Services issued significant new guidance for implementing its permissive exclusion authority under Section 1128(b)(15) of the Social Security Act. As background, "exclusion" refers to the ability of the OIG to exclude individuals or entities from participating in the federal health care programs. Section 1128(b)(15) specifically authorizes the OIG to exclude an owner, officer or managing employee of a sanctioned entity, i.e., health care provider, supplier, or manufacturer, from participation in federal health care programs.

The OIG's new guidance sets out non-binding factors which the OIG intends to consider in deciding whether to impose exclusion on owners, officers and managing employees. This memorandum summarizes the OIG's new guidance and encourages our clients to take proactive measures against potential abuses and misconduct, as exclusion likely precludes an individual from employment with any health care provider or supplier. We have also noted below recent statements by officials of the Food & Drug Administration concerning the bringing of misdemeanor charges against executives of entities that promote off-label uses of their products.

Please see full Alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.